Development and validation of prognostic nomograms for patients with metastatic prostate cancer

[1] Siegel RL(2018)Cancer statistics CA Cancer J Clin 68 7-30

[2] Miller KD(2014)Distribution of metastatic sites in patients with prostate cancer: a population-based analysis Prostate 74 210-216

[3] Jemal A(1941)Studies on prostatic cancer I: the effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate Cancer Res 168 293-297

[4] Gandaglia G(2018)Management of patients with advanced prostate cancer: the report of the advanced prostate cancer consensus conference APCCC 2017 Eur Urol 73 178-211

[5] Abdollah F(2017)EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer Eur Urol 71 630-642

[6] Schiffmann J(2014)No improvement noted in overall or cause-specific survival for men presenting with metastatic prostate cancer over a 20-year period Cancer 120 818-823

[7] Trudeau V(2017)The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging CA Cancer J Clin 67 93-99

[8] Shariat SF(2018)The impact of marriage on the overall survival of prostate cancer patients: a surveillance, epidemiology, and end results (SEER) analysis Can Urol Assoc J 10 556-567

[9] Kim SP(2019)Prognostic significance of young age and non-bone metastasis at diagnosis in patients with metastatic prostate cancer: a SEER population-based data analysis J Cancer 17 e130-e139

[10] Perrotte P(2019)Rates of positive surgical margins and their effect on cancer-specific mortality at radical prostatectomy for patients with clinically localized prostate cancer Clin Genitourin Cancer 10 1061-1067

[1] Siegel RL(2018)Cancer statistics CA Cancer J Clin 68 7-30

[2] Miller KD(2014)Distribution of metastatic sites in patients with prostate cancer: a population-based analysis Prostate 74 210-216

[3] Jemal A(1941)Studies on prostatic cancer I: the effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate Cancer Res 168 293-297

[4] Gandaglia G(2018)Management of patients with advanced prostate cancer: the report of the advanced prostate cancer consensus conference APCCC 2017 Eur Urol 73 178-211

[5] Abdollah F(2017)EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer Eur Urol 71 630-642

[6] Schiffmann J(2014)No improvement noted in overall or cause-specific survival for men presenting with metastatic prostate cancer over a 20-year period Cancer 120 818-823

[7] Trudeau V(2017)The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging CA Cancer J Clin 67 93-99

[8] Shariat SF(2018)The impact of marriage on the overall survival of prostate cancer patients: a surveillance, epidemiology, and end results (SEER) analysis Can Urol Assoc J 10 556-567

[9] Kim SP(2019)Prognostic significance of young age and non-bone metastasis at diagnosis in patients with metastatic prostate cancer: a SEER population-based data analysis J Cancer 17 e130-e139

[10] Perrotte P(2019)Rates of positive surgical margins and their effect on cancer-specific mortality at radical prostatectomy for patients with clinically localized prostate cancer Clin Genitourin Cancer 10 1061-1067